So for every new Vaccine, Anteobind will be ebbed for circa 20y cycle "upon regulatory approval of their new vaccines, AnteoBind will form part of the core vaccine manufacturing process, which means any future process change requires a new regulatory filing." Annc 30Jul
As for off-take. Some observations.
""AnteoTech provided 5-year term of Agreement with US$370,000 minimum annual take or pay orders." PR 2Aug.
=> Sweet, that'll chip away at the bottom line. Nice under pin.
"Supply Agreement contains pricing to support the anticipated future increase in demand." PR 2Aug
=> Bulk discounts? Well, let's call that Volume friendy pricing. Chef says, "Push the NXT."
"The Company has existing capacity to meet the customer requirements." PR 2Aug
=> But wait the X-Shed only produces 20K and that's for Batteries isn't it? Does the shed capability include Medical Grade Anteobind too?
"Serum Institute of India produces over 1.5bn vaccine doses and US$3bn revenues annually. First US$185,000 order for the Product received with shipment and payment in August 2024." PR 2Aug
=>Cash injection this month. NOT 90day receipts. See item above: Anteotech has Shelf Life ready stock.
ADO Price at posting:
2.0¢ Sentiment: Buy Disclosure: Held
